Pharmaceutical multinational corporations are advocating for relief from price controls on patented drugs, citing issues within the patent system that contribute to elevated drug prices. Concerns have been raised about the manipulation of the patent system by large pharmaceutical companies, which reportedly extends monopolies on crucial prescription medications. Senator Peter Welch emphasized the need for reform to enhance market competition and protect consumers from exorbitant prices. Furthermore, recent analyses have highlighted that errors in U.S. Patent Office software may inadvertently prolong patent durations for drugs. A new study proposes addressing these patent system abuses by correcting a lesser-known method that currently allows for the extension of patent life.